Christine advises life sciences clients on a wide range of intellectual property matters. With a focus on strategic patent counseling and domestic and international patent prosecution in the areas of organic chemistry, medicinal chemistry, drug discovery, cancer therapeutics, and pharmaceuticals, Christine’s experience ranges from small molecule pharmaceuticals to large molecule conjugates. Her practice also includes patent due diligence on both investor-side and company-side for private and public financial transactions. She also has experience with post-issuance proceedings, Patent Term Extension strategy, and Orange Book patent listing strategy.

Before her legal career, Christine worked at a pioneering pharmaceutical company as a research assistant developing selective HDAC inhibitors. Her doctoral research at Colorado State University centered on the natural product largazole, a potent HDAC inhibitor, and structure–activity relationship studies to design more potent and selective cancer therapeutics.

While at Northeastern University, Christine completed two co-ops at a leading biomedical research institute, where she studied metabolite identification and ocular metabolism in the Metabolism and Pharmacokinetics group, with a focus on biotransformation.